CHICAGO--(BUSINESS WIRE)--Rottendorf Pharmaceuticals, a top 20 contract development and manufacturing organization (CDMO) currently producing 600 products for more than 200 clients worldwide, announced it signed in the last quarter three formulation development projects and two commercial transfer projects with multiple Top 5 Pharmaceutical and Biopharmaceutical companies. The five new projects capped a strong year of growth for the U.S.-based subsidiary of Rottendorf Pharma GmbH, which has more than doubled its share of corporate revenue since 2011.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
